Alpha-MSH and MIF-I effects on catecholamine levels and synthesis in various rat brain areas
- PMID: 4815
- DOI: 10.1016/0091-3057(75)90010-6
Alpha-MSH and MIF-I effects on catecholamine levels and synthesis in various rat brain areas
Abstract
Attempts were made to find a biochemical correlate with previously observed behavioral alterations after administration of alpha-melanocyte-stimulating hormone (MSH) and MSH release-inhibiting factor (MIF-I). Brains of intact and hypophysectomized (hypox) rats were analyzed for endogenous catecholamine levels and the disappearance rate of endogenous norepinephrine (NE) after treatment with the tyrosine hydroxylase inhibitor alpha-methyl-para-tyrosine (AMPT). The studies undertaken show the following: (1) After the injection of MSH (100 mug/kg IP daily x 3) and AMPT, samples in different groups of intact and hypox rats were taken at 0, 1, 2, 4 and 6 hrs in 7 different brain areas. In the mid-brain area for the intact group of rats, the rate of disappearance of NE was faster and for the hypox rats it was slower than the rate for control rats not treated with the peptides. NE levels in the same area at time 0 were 11 percent lower than controls in hypox rats and unchanged in unoperated animals. (2) After the injection of MIF-I (20 mg/kg IP daily x 3) in similar experiments as with MSH, a reduced rate (p less than 0.05) of NE disappearance for the first 4 hr and an increased rate (p less than 0.05) of NE disappearance for the last 2 hr of the experiments occurred for both the intact and hypox rats in the mid-brain area where endogenous NE levels were lowered by 11 and 12 percent at 0 min. In no other brain areas were alterations in NE breakdown found in both the intact and hypox rat groups. Behavioral changes have been found previously under similar experimental conditions in both intact and hypox rats. (3) Rates of dopamine disappearance in experiments similar to those described for NE disappearance indicated that in the striatal brain area no change was found in the intact rats after either MSH or MIF-I, whereas a decrease in DA disappearance was found for hypox rats during the six hour experimental period only after MSH. The results indicate that a correlation between behavioral changes, rates of disappearance and endogenous levels of NE in the mid-brain area may occur after MIF-I at the times examined but that a similar correlation for MSH did not appear likely.
Similar articles
-
alpha-MSH, MIF-I and melatonin: effects on novelty-induced defecation, plasma 11-OHCS and central catecholamines in rats.Peptides. 1981;2 Suppl 1:143-54. doi: 10.1016/0196-9781(81)90069-3. Peptides. 1981. PMID: 6115365
-
Investigations on alpha-MSH and MIF-1 effects on cyclic AMP levels in rat brain.Pharmacol Biochem Behav. 1976;5(Suppl 1):117-20. doi: 10.1016/0091-3057(76)90338-5. Pharmacol Biochem Behav. 1976. PMID: 13410
-
Alpha-MSH and MIF-2 effects on serotonin levels and accumulation in various rat brain areas.Pharmacol Biochem Behav. 1975 Nov-Dec;3(6):1011-5. doi: 10.1016/0091-3057(75)90009-x. Pharmacol Biochem Behav. 1975. PMID: 4814
-
CNS and pituitary effects of hypothalamic peptides and MSH.Essays Neurochem Neuropharmacol. 1977;1:139-76. Essays Neurochem Neuropharmacol. 1977. PMID: 30623 Review.
-
Alpha-melanocyte-stimulating hormone and behavior.Neurosci Biobehav Rev. 1982 Fall;6(3):297-310. doi: 10.1016/0149-7634(82)90042-2. Neurosci Biobehav Rev. 1982. PMID: 6294567 Review.
Cited by
-
On the optimal dosage of Pro-Leu-Gly-NH2 (MIF) in neuropharmacological tests and clinical use.Naunyn Schmiedebergs Arch Pharmacol. 1977 Jun;298(2):79-81. doi: 10.1007/BF00508614. Naunyn Schmiedebergs Arch Pharmacol. 1977. PMID: 18686
-
Plasma beta-lipotropin levels in Parkinson's disease.J Neural Transm. 1982;53(1):75-82. doi: 10.1007/BF01243521. J Neural Transm. 1982. PMID: 6278076
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous